Stay updated on RX-5902 in Triple Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the RX-5902 in Triple Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RX-5902 in Triple Negative Breast Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Locations have been consolidated into a single 'Locations' section listing multiple US sites (Arizona, Colorado, Illinois, Michigan, New Jersey, New York, South Carolina, Virginia), replacing the previous state-specific subsections; the page footer now shows Revision: v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T13:30:14.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and v3.2.0 was removed. These are administrative versioning changes with no impact on study details; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:51:38.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Deleted the site-wide operating-status disclaimer about potential data delays due to government funding; it previously advised that information may not be up to date and directed users to opm.gov for updates.
    Difference
    0.4%
    Check dated 2025-11-17T17:30:22.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Only minor UI/layout and styling changes are visible; core study details, eligibility criteria, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T11:39:51.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Summary: The page now displays a funding-status notice and announces a major version upgrade to v3.2.0, replacing the previous v3.1.0.
    Difference
    5%
    Check dated 2025-10-05T17:20:57.000Z thumbnail image
  9. Check
    101 days ago
    Change Detected
    Summary
    - Version updated from v3.0.2 to v3.1.0. This is a metadata change indicating a newer release; no other page content appears to be altered.
    Difference
    0.1%
    Check dated 2025-09-28T10:06:21.000Z thumbnail image

Stay in the know with updates to RX-5902 in Triple Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RX-5902 in Triple Negative Breast Cancer Clinical Trial page.